Down syndrome affects not just chromosome 21 but impacts gene expression across the entire genome, alters how genes are epigenetically regulated and spatially organized, causes long-lasting brain inflammation, and disrupts cellular metabolism. These interconnected changes influence brain development and function, but new therapies targeting these areas offer hope for improved cognition and health.